Cardiovascular disease represents a systemic collapse of velocity and frequency within the Kinetic Density framework, validated across major diseases at 13.1-Sigma (p < 10^-38).
Absolute Event Rate: 0% vs 0%
This document is a scientific research manuscript in the field of biophysics and systems engineering. The information contained herein does not constitute medical advice, diagnosis, or therapeutic indication. No decisions regarding treatments, discontinuation of medications, or changes in health protocols should be made without the direct guidance and supervision of a duly registered physician. The content of this work is strictly theoretical and experimental, intended for peer review and academic validation. ABSTRACT: The LE-MS24 manuscript establishes a milestone in the Law of Existence series, expanding the Kinetic Density (Ω) framework to the four major categories of non-infectious diseases responsible for the majority of global morbidity. The work proves that cardiovascular diseases, Alzheimer's (neurodegeneration), Type 2 Diabetes, and autoimmune diseases are not isolated phenomena, but specific patterns of collapse of the parameters v, fᵥ, r, and C in the master equation = k (v fᵥ / r) C. KEY POINTS OF UNIFICATION: Disease as a Process Failure: Unlike conventional medicine, which focuses on the "defective biological product, " the LE-MS24 identifies the failure in the kinetic manufacturing process. Parameter Mapping: Cardiovascular: Collapse of v (velocity) and fᵥ (frequency) on a systemic scale. Alzheimer's: Collapse of fᵥ and C (coherence) on a neural scale. Type 2 Diabetes: Collapse of fᵥ and C on a metabolic and pancreatic scale. Autoimmune: Primary collapse of C (loss of energy). (organizational coherence of the immune system). Unprecedented Statistical Validation: Using Fisher's exact method, the manuscript achieves a combined confidence of 13. 1-Sigma (p < 10^-38), based on decades of independent clinical literature that measured these parametric deviations without knowledge of the Kinetic Density framework. CONCLUSION: The LE-MS24 offers a new taxonomy for medicine, allowing the identification of which kinetic parameter failed first in each pathology. This paves the way for a new generation of process-level interventions focused on restoring the organism's axial coherence and kinetic density.
REGIVALDO MOTA DE ALMEIDA (Sun,) reported a other. Cardiovascular disease represents a systemic collapse of velocity and frequency within the Kinetic Density framework, validated across major diseases at 13.1-Sigma (p < 10^-38).